van Agthoven M - Search Results

1

Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?

Schawo S, van der Kolk A, Bouwmans C, Annemans L, Postma M, Buitelaar J, van Agthoven M, Hakkaart-van Roijen L. Schawo S, et al. Among authors: van agthoven m, van der kolk a. Pharmacoeconomics. 2015 May;33(5):489-509. doi: 10.1007/s40273-015-0259-x. Pharmacoeconomics. 2015. PMID: 25715975 Free PMC article.

2

Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The Netherlands.

Faber A, van Agthoven M, Kalverdijk LJ, Tobi H, de Jong-van den Berg LT, Annemans L, Postma MJ. Faber A, et al. Among authors: van agthoven m. CNS Drugs. 2008;22(2):157-70. doi: 10.2165/00023210-200822020-00006. CNS Drugs. 2008. PMID: 18193926

3

Societal Costs and Qol of Children with Adhd and their Parents: a Comparison to a Reference Group from the General Population.

Van Der Kolk A, van Agthoven M, Bouwmans C, Buitelaar JK, Hakkaart L. Van Der Kolk A, et al. Among authors: van agthoven m. Value Health. 2014 Nov;17(7):A462. doi: 10.1016/j.jval.2014.08.1284. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201302 Free article. No abstract available.

4

Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands.

van der Kolk A, Bouwmans CA, Schawo SJ, Buitelaar JK, van Agthoven M, Hakkaart-van Roijen L. van der Kolk A, et al. Among authors: van agthoven m. Springerplus. 2015 May 15;4:224. doi: 10.1186/s40064-015-0978-7. eCollection 2015. Springerplus. 2015. PMID: 26155437 Free PMC article.

5

Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.

van der Kolk A, Bouwmans CA, Schawo SJ, Buitelaar JK, van Agthoven M, Hakkaart-van Roijen L. van der Kolk A, et al. Among authors: van agthoven m. J Ment Health Policy Econ. 2014 Sep;17(3):119-29. J Ment Health Policy Econ. 2014. PMID: 25543115

6

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial.

Kooij JJ, Rösler M, Philipsen A, Wächter S, Dejonckheere J, van der Kolk A, van Agthoven M, Schäuble B. Kooij JJ, et al. Among authors: van agthoven m, van der kolk a. BMC Psychiatry. 2013 Jan 24;13:36. doi: 10.1186/1471-244X-13-36. BMC Psychiatry. 2013. PMID: 23347693 Free PMC article. Clinical Trial.

7

Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD.

Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, Buitelaar J, van Roijen L. Bouwmans C, et al. Among authors: van roijen l, van agthoven m, van der kolk a. Eur J Health Econ. 2014 Dec;15(9):967-77. doi: 10.1007/s10198-013-0540-x. Eur J Health Econ. 2014. PMID: 24233919

8

[Cost-effectiveness in Dutch mental health care: future because of ROM?].

van Agthoven M, van der Kolk A, Knegtering H, Delespaul PA, Arends J, Jeurissen PP, Krabbe PF, Huijsman R, Luijk R, De Beurs E, Hakkaart-Van Roijen L, Bruggeman R. van Agthoven M, et al. Among authors: van der kolk a. Tijdschr Psychiatr. 2015;57(9):672-9. Tijdschr Psychiatr. 2015. PMID: 26401609 Free article. Dutch.

9

Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands.

Pechlivanoglou P, Vehof J, van Agthoven M, de Jong-van den Berg LT, Postma MJ. Pechlivanoglou P, et al. Among authors: van agthoven m. Clin Ther. 2010 Jan;32(1):108-18. doi: 10.1016/j.clinthera.2010.01.008. Clin Ther. 2010. PMID: 20171417

10

Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands.

Vellopoulou A, van Agthoven M, van der Kolk A, de Knegt RJ, Berdeaux G, Cure S, Bianic F, Lamotte M. Vellopoulou A, et al. Among authors: van agthoven m, van der kolk a. Appl Health Econ Health Policy. 2014 Dec;12(6):647-59. doi: 10.1007/s40258-014-0120-y. Appl Health Econ Health Policy. 2014. PMID: 25103219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page